middle.news
Radiopharm Theranostics Advances RV01 with Promising Preclinical Data
11:45pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Radiopharm Theranostics Advances RV01 with Promising Preclinical Data
11:45pm on Monday 2nd of June, 2025 AEST
Key Points
Lu177-B7H3-mAb RV01 shows high tumour uptake and favourable biodistribution
Fc region modifications shorten antibody half-life, potentially reducing toxicity
Preclinical package completion supports mid-2025 IND submission
Phase 1 therapeutic basket study expected to start in late 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Radiopharm Theranostics (ASX:RAD)
OPEN ARTICLE